Jianhua Ju Selected Research

tautomycin

4/2009	Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
3/2009	Tautomycin suppresses growth and neuroendocrine hormone markers in carcinoid cells through activation of the Raf-1 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianhua Ju Research Topics

Disease

11	Neoplasms (Cancer) 11/2021 - 03/2008
7	Tuberculosis (Tuberculoses) 04/2022 - 01/2017
2	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2007 - 01/2007
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Wilms Tumor (Wilm's Tumor) 04/2019
1	Trophoblastic Neoplasms (Trophoblastic Tumor) 04/2019
1	Rhabdomyosarcoma 04/2019
1	Triple Negative Breast Neoplasms 01/2019
1	Human Influenza (Influenza) 04/2018
1	Infections 10/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Prostatic Neoplasms (Prostate Cancer) 07/2015
1	Melanoma (Melanoma, Malignant) 02/2012
1	Clostridium Infections 07/2011
1	Diarrhea 02/2011
1	medullary Thyroid cancer 04/2009
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2009
1	Carcinoid Tumor (Carcinoid) 03/2009

Drug/Important Bio-Agent (IBA)

3	PolyketidesIBA 11/2021 - 02/2009
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 10/2017
2	Antitubercular AgentsIBA 04/2020 - 01/2017
2	atratumycinIBA 09/2019 - 01/2019
2	FidaxomicinIBA 07/2011 - 02/2011
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2011 - 02/2011
2	glutarimideIBA 10/2009 - 02/2009
2	isomigrastatinIBA 10/2009 - 02/2009
2	tautomycinIBA 04/2009 - 03/2009
2	Antineoplastic Agents (Antineoplastics)IBA 03/2008 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 11/2007 - 01/2007
2	C 1027IBA 11/2007 - 01/2007
1	Rifabutin (Ansamycin)FDA Link 11/2021
1	kendomycinIBA 11/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2020
1	cyclopeninIBA 01/2020
1	grincamycin BIBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ZincIBA 01/2020
1	Cyclic PeptidesIBA 11/2019
1	DepsipeptidesIBA 09/2019
1	Dactinomycin (Actinomycin)FDA LinkGeneric 04/2019
1	Biological ProductsIBA 01/2019
1	Ribavirin (Virazole)FDA LinkGeneric 04/2018
1	borrelidinIBA 01/2018
1	etamycinIBA 10/2017
1	StreptograminsIBA 10/2017
1	griseoviridinIBA 10/2017
1	ProdrugsIBA 07/2015
1	Cisplatin (Platino)FDA LinkGeneric 03/2015
1	KetosesIBA 03/2015
1	marthiapeptide AIBA 12/2012
1	grincamycinIBA 02/2012
1	GlycosidesIBA 07/2011
1	tautomycetinIBA 04/2009
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2009
1	Glycogen Synthase (Synthase I)IBA 04/2009
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2009
1	Hormones (Hormone)IBA 03/2009
1	migrastatinIBA 02/2009
1	lactimidomycinIBA 02/2009